Vontier (VNT) Competitors $35.46 -1.01 (-2.77%) Closing price 06/13/2025 03:59 PM EasternExtended Trading$35.51 +0.05 (+0.14%) As of 06/13/2025 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VNT vs. TER, RVTY, AVTR, BIO.B, NVMI, MIR, ST, CAMT, TXG, and TRNSShould you be buying Vontier stock or one of its competitors? The main competitors of Vontier include Teradyne (TER), Revvity (RVTY), Avantor (AVTR), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Mirion Technologies (MIR), Sensata Technologies (ST), Camtek (CAMT), 10x Genomics (TXG), and Transcat (TRNS). These companies are all part of the "measuring and control equipment" industry. Vontier vs. Its Competitors Teradyne Revvity Avantor Bio-Rad Laboratories Nova Mirion Technologies Sensata Technologies Camtek 10x Genomics Transcat Vontier (NYSE:VNT) and Teradyne (NASDAQ:TER) are both business services companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, community ranking, earnings, institutional ownership, risk and profitability. Do institutionals & insiders believe in VNT or TER? 95.8% of Vontier shares are owned by institutional investors. Comparatively, 99.8% of Teradyne shares are owned by institutional investors. 1.0% of Vontier shares are owned by insiders. Comparatively, 0.2% of Teradyne shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts prefer VNT or TER? Vontier presently has a consensus price target of $44.83, indicating a potential upside of 26.43%. Teradyne has a consensus price target of $114.67, indicating a potential upside of 38.02%. Given Teradyne's higher probable upside, analysts plainly believe Teradyne is more favorable than Vontier.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vontier 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71Teradyne 2 Sell rating(s) 3 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.63 Which has more risk & volatility, VNT or TER? Vontier has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500. Comparatively, Teradyne has a beta of 1.69, indicating that its share price is 69% more volatile than the S&P 500. Does the media prefer VNT or TER? In the previous week, Teradyne had 6 more articles in the media than Vontier. MarketBeat recorded 11 mentions for Teradyne and 5 mentions for Vontier. Vontier's average media sentiment score of 1.32 beat Teradyne's score of 1.11 indicating that Vontier is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vontier 3 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teradyne 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in VNT or TER? Teradyne received 39 more outperform votes than Vontier when rated by MarketBeat users. However, 53.93% of users gave Vontier an outperform vote while only 48.07% of users gave Teradyne an outperform vote. CompanyUnderperformOutperformVontierOutperform Votes4853.93% Underperform Votes4146.07% TeradyneOutperform Votes8748.07% Underperform Votes9451.93% Is VNT or TER a better dividend stock? Vontier pays an annual dividend of $0.10 per share and has a dividend yield of 0.3%. Teradyne pays an annual dividend of $0.48 per share and has a dividend yield of 0.6%. Vontier pays out 4.1% of its earnings in the form of a dividend. Teradyne pays out 13.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Teradyne has raised its dividend for 1 consecutive years. Teradyne is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Which has better valuation & earnings, VNT or TER? Teradyne has lower revenue, but higher earnings than Vontier. Vontier is trading at a lower price-to-earnings ratio than Teradyne, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVontier$2.96B1.77$422.20M$2.4614.41Teradyne$2.91B4.59$542.37M$3.5423.47 Is VNT or TER more profitable? Teradyne has a net margin of 19.23% compared to Vontier's net margin of 14.17%. Vontier's return on equity of 43.22% beat Teradyne's return on equity.Company Net Margins Return on Equity Return on Assets Vontier14.17% 43.22% 10.38% Teradyne 19.23%19.08%14.47% SummaryTeradyne beats Vontier on 15 of the 22 factors compared between the two stocks. Get Vontier News Delivered to You Automatically Sign up to receive the latest news and ratings for VNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VNT vs. The Competition Export to ExcelMetricVontierFluid meters & counting devices IndustryBusiness SectorNYSE ExchangeMarket Cap$5.24B$6.19B$14.17B$19.68BDividend Yield0.27%0.41%2.58%3.81%P/E Ratio12.8935.1033.2934.98Price / Sales1.775.07313.3442.85Price / Cash10.1425.4930.9317.51Price / Book4.978.375.324.78Net Income$422.20M$273.57M$194.72M$1.02B7 Day Performance-1.85%-1.74%-2.31%0.82%1 Month Performance-3.82%-1.74%0.01%1.74%1 Year Performance-7.00%11.50%24.05%10.57% Vontier Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VNTVontier4.013 of 5 stars$35.46-2.8%$44.83+26.4%-8.5%$5.24B$2.96B12.898,100Positive NewsTERTeradyne4.8136 of 5 stars$86.80+1.8%$114.67+32.1%-43.7%$13.92B$2.91B26.076,500Positive NewsAnalyst RevisionGap DownRVTYRevvity3.8565 of 5 stars$92.91+1.0%$125.64+35.2%-15.6%$10.95B$2.77B42.0416,700Positive NewsAVTRAvantor4.7673 of 5 stars$13.47+3.0%$18.88+40.2%-40.6%$9.18B$6.69B12.9514,500Positive NewsShort Interest ↑BIO.BBio-Rad LaboratoriesN/A$250.08flatN/A-11.8%$7.00B$2.54B-3.858,200NVMINova1.935 of 5 stars$220.89+1.8%$277.00+25.4%-6.4%$6.49B$743.95M38.481,180Positive NewsAnalyst RevisionGap DownMIRMirion Technologies0.6632 of 5 stars$20.49+3.0%$18.75-8.5%+90.7%$4.75B$870.20M-107.842,870Short Interest ↑STSensata Technologies4.7913 of 5 stars$27.79+2.8%$34.08+22.7%-30.0%$4.06B$3.84B33.0820,800CAMTCamtek4.2469 of 5 stars$74.44+1.3%$90.78+21.9%-39.9%$3.39B$450.86M30.76400Analyst RevisionGap DownTXG10x Genomics4.2049 of 5 stars$10.09+7.1%$15.81+56.7%-47.2%$1.16B$624.66M-6.641,240Analyst ForecastGap DownHigh Trading VolumeTRNSTranscat2.9256 of 5 stars$76.68-1.7%$114.00+48.7%-35.6%$714.50M$278.42M41.45920 Related Companies and Tools Related Companies Teradyne Competitors Revvity Competitors Avantor Competitors Bio-Rad Laboratories Competitors Nova Competitors Mirion Technologies Competitors Sensata Technologies Competitors Camtek Competitors 10x Genomics Competitors Transcat Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:VNT) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vontier Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vontier With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.